SAN FRANCISCO (Reuters) - Eli Lilly and Co said on Monday that U.S. insurers are increasing pressure on the price of diabetes medications as they switch coverage from certain drugs to others to trim costs.
via Reuters: Health News Read More Here..
No comments:
Post a Comment